Parallel Advisors »

Apogee Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $646 11 58.73

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Amazon.com Stock (AMZN)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Vanguard Total Stk Mkt Etf (VTI)
Costco Wholesale Corp Stock (COST)

View all positions for Parallel Advisors

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
BlackRock
Driehaus Capital Management
Fairmount Funds Management
Perceptive Advisors
Vanguard Group
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners
Franklin Resources
Geode Capital Management

View all funds holding Apogee Therapeutics